“Let’s Talk Cost” addresses the rising and increasingly unsustainable healthcare costs and includes information labeling artificial discs as “ineffective.” Dr. Coric argues the information presented is overly simplistic and lacks backing from credible medical sources.
Dr. Coric states that while insurance companies have the right to withhold coverage of medical devices, such as artificial discs, it is not acceptable to label such technologies as ineffective despite the medical evidence to the contrary.
More Articles on Spine:
Demanding Data-Driven Spine Treatments: Q&A With Dr. Jeffrey Wang of UCLA Spine
Dr. Eric Woodard to Perform Surgeries in FDA Trial of InVivo Device
Advocating for Patient Access & Surgeon Needs: Q&A With Dr. Eeric Truumees of Seton Spine and Scoliosis Center
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
